Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Cuts to Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass.

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today ...

However, Mr Jervis only received a course of antibiotics some 20 hours after it was noted that he needed the medication. Mr ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...